Tigecycline

This classification denotes an antibiotic with the molecular formula C29H39N5O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 70JE2N95KR, chemically known as 2-naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4s,4as,5ar,12as)- but generally known as tigecycline, which bears US NIH Compound Identifier 5282044. European Medicines Agency schedules Tigecycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16467MIG. The term TIGECYCLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3, 2002, List 48). World Health Organization schedules tigecycline in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule tigecycline under HS 29413000 and SITC 54133. As of Q4 2014, TIGECYCLINE remains the US FDA Preferred Term for this commodity. Tigecycline bears US NLM identifiers UMLS ID C1260298 and NCI Concept Code C72865. SMILES: OC12C(CC3C(=C(O)C4C(C3)C(N(C)C)CC(NC(=O)CNC(C)(C)C)C4O)C1=O)C(N(C)C)C(=O)C(=C(\O)N)\C2=O.